ADVERTISEMENT
  • The Membership Club
  • PT Hausa
  • About Us
  • Advert Rates
  • Careers
  • Contact Us
Tuesday, March 2, 2021
Premium Times Nigeria
  • Home
  • COVID-19
  • News
    • Headline Stories
    • Top News
    • More News
    • Foreign
  • Investigations
  • Business
    • News Reports
    • Financial Inclusion
    • Analysis and Data
    • Business Specials
    • Opinion
    • Oil/Gas Reports
      • FAAC Reports
      • Revenue
  • Opinion
  • Health
    • News Reports
    • Investigations
    • Data and Infographics
    • Health Specials
    • Features
    • Events
    • Primary Health Tracker
  • Agriculture
    • News Report
    • Research & Innovation
    • Data & Infographics
    • Special Reports/Features
    • Investigations
    • Interviews
    • Markets
  • Arts/Life
    • Arts/Books
    • Kannywood
    • Lifestyle
    • Music
    • Nollywood
    • Travel
  • Sports
    • Football
    • More Sports News
    • Sports Features
  • Projects
    • Parliament Watch
    • Panama Papers
    • Paradise Papers
    • AGAHRIN
  • Home
  • COVID-19
  • News
    • Headline Stories
    • Top News
    • More News
    • Foreign
  • Investigations
  • Business
    • News Reports
    • Financial Inclusion
    • Analysis and Data
    • Business Specials
    • Opinion
    • Oil/Gas Reports
      • FAAC Reports
      • Revenue
  • Opinion
  • Health
    • News Reports
    • Investigations
    • Data and Infographics
    • Health Specials
    • Features
    • Events
    • Primary Health Tracker
  • Agriculture
    • News Report
    • Research & Innovation
    • Data & Infographics
    • Special Reports/Features
    • Investigations
    • Interviews
    • Markets
  • Arts/Life
    • Arts/Books
    • Kannywood
    • Lifestyle
    • Music
    • Nollywood
    • Travel
  • Sports
    • Football
    • More Sports News
    • Sports Features
  • Projects
    • Parliament Watch
    • Panama Papers
    • Paradise Papers
    • AGAHRIN
Premium Times Nigeria
BUA Group Ad BUA Group Ad BUA Group Ad
ADVERTISEMENT
COVID-19 vaccine vials [PHOTO CREDIT: BioWorld]

COVID-19 vaccine vials [PHOTO CREDIT: BioWorld]

WHO to secure 40m doses of Pfizer-BioNTech COVID-19 vaccine

The agreement is coming under the UN-led COVAX equitable vaccine supply programme.

byAgency Report
January 23, 2021
3 min read

The World Health Organisation (WHO) has announced the signing of an advance purchase agreement securing up to 40 million doses of the Pfizer-BioNTech COVID vaccine.

The agreement is coming under the UN-led COVAX equitable vaccine supply programme.

The UN health agency, in a statement posted on its website, stated that the rollout for the vaccine would commence with successful execution of supply agreement.

According to the statement, WHO’s Director-General, Tedros Ghebreyesus, disclosed the plan at COVID-19 news conference at WHO headquarters in Geneva.

Mr Ghebreyesus said pending emergency authorisation, close to 150 million doses of the AstraZeneca/Oxford vaccine should also be available for COVAX to distribute, up to the end of March.

“Together, these announcements mean COVAX could begin delivering doses in February, provided we can finalise a supply agreement.

“The deal will also open the door for countries with spare doses, to donate them,’’ he said.

He said, “The urgent and equitable rollout of vaccines was not just a moral imperative; it’s also a strategic and economic imperative.

“This agreement with Pfizer will help to enable COVAX to save lives, stabilise health systems and drive the global economic recovery.”

RelatedNews

Nigeria receives 3.94 million doses of COVID-19 vaccines

ANALYSIS: One year after, five gaps in Nigeria’s management of COVID-19

The Corona Vaccine Wars: The Poor Will Die First, By Owei Lakemfa

Nigeria’s COVID-19 infections hit 150,000

In addition, he said that UN Children’s Fund (UNICEF) was also playing a “vital role” in preparing countries for the delivery and rollout of vaccines.

The statement quoted UNICEF Executive Director, Henrietta Fore, as saying, “These purchase agreements open the door for these lifesaving vaccines to become available to people in the most vulnerable countries.

“But at the same time we are securing vaccines, we must also ensure that countries are ready to receive them, deploy them, and build trust in them.”

Dangote adbanner 728x90_2 (1)

It said the COVAX Facility would provide all 190 participating economies with an indicative allocation of doses by the end of January.

“This indicative allocation will provide interim guidance to participants – offering a minimum planning scenario to enable preparations for the final allocation of the number of doses each participant will receive in the first rounds of vaccine distribution.

“COVAX now has agreements in place to access just over two billion doses of several promising vaccine candidates.

“Negotiations continue for further doses to be secured through existing Research and Development agreements by COVAX co-lead the Coalition for Epidemic Preparedness Innovations (CEPI), through evaluations of new products with promising results and through contributions from donors.’’

WHO said COVAX anticipated providing participating economies doses of safe and effective vaccines – enough to protect health care and other frontline workers as well as some high-risk individuals from first quarter.

It said “The aim is to protect at least 20 per cent of each participating population by the end of the year – unless a participant has requested a lower percentage of doses.

ADVERTISEMENT

“At least 1.3 billion of these doses will be made available to the 92 economies eligible for the Gavi COVAX AMC by the end of 2021.

“To meet its goal of securing two billion safe and effective vaccines in 2021, COVAX has built a diverse portfolio of vaccine candidates which mitigates the risk of a product failing development, production or regulatory processes, and ensures availability of products suitable for various contexts and settings.

“This work will continue at pace to enable further supply of vaccines suitable for use across a wide range of populations and settings in 2021 and beyond.’’

The statement, however, quoted Richard Hatchett, CEO of CEPI, as saying, “the progress in vaccine development so far has been extraordinary.

“It is clear that we are now assembling the tools we need to bring the acute phase of the pandemic to an end. But we cannot afford to slow our efforts given the speed with which this pandemic continues to wreak havoc.

“The emergence of new variants of COVID-19 puts into sharp focus the need for us to be one step ahead of the virus by continuing to invest in vaccine Research and Development (R&D).

“It is important to invest in R&D, specifically for next-generation vaccine candidates and to be ready for strain changes in existing vaccines – to ensure we have the tools to meet the needs of all populations in all countries for the long term.”

(NAN)

  • WhatsApp
  • Tweet
  • Email
  • Print
  • Telegram
  • More
  • Share on Tumblr
  • Pocket

Support PREMIUM TIMES' journalism of integrity and credibility

Good journalism costs a lot of money. Yet only good journalism can ensure the possibility of a good society, an accountable democracy, and a transparent government.

For continued free access to the best investigative journalism in the country we ask you to consider making a modest support to this noble endeavour.

By contributing to PREMIUM TIMES, you are helping to sustain a journalism of relevance and ensuring it remains free and available to all.

Donate


TEXT AD: To advertise here . Call Willie +2347088095401...


JOIN THE CONVERSATION

  • Disqus (0)
premiumtimes



PT Mag Campaign AD

Previous Post

NPFL: Rangers captain sure of victory against Lobi Stars

Next Post

Kidnapping: Government demolishes hotel in Calabar

Agency Report

Agency Report

More News

Nigeria takes delivery of the first batch of Oxford-AstraZeneca #COVID19Vaccines from #COVAX.

Nigeria receives 3.94 million doses of COVID-19 vaccines

March 2, 2021
Arrival of the COVID-19 vaccines at the Nnamdi Azikiwe International airport

Nigeria receives 3.94 million doses of COVID-19 vaccines

March 2, 2021
COVID-19 vaccine. [CREDIT: Duetsche Welle]

COVID-19: Nine things to know about Oxford/AstraZeneca vaccine arriving Nigeria

March 2, 2021
Covid-19 Laboratory test [PHOTO CREDIT: The Scientist Magazine]

Again, Nigeria records ‘low’ daily infections with 360 new cases

March 2, 2021
FILE: Drones conveying healthcare equipment used to illustrate the story [PHOTO: Drones in Healthcare]

Cross River to deploy drones to supply healthcare materials – Official

March 1, 2021
COVID-19 vaccination [PHOTO CREDIT: WHO]

Nigeria launches strategy for effective COVID-19 vaccination

March 1, 2021
Next Post
The demolished Save Side Hotel in Calabar

Kidnapping: Government demolishes hotel in Calabar

Sunday Igboho [PHOTO: BBC Pidgin]

Oyo Crisis: Who is Sunday Igboho, self-acclaimed Yoruba warrior?

Discussion about this post

Search

#EndSARS: Latest Updates




Polaris Bank


JAIZ Ad


NITDA Ad





Glo Ad

Subscribe to News via Email

Enter your email address and receive notifications of news by email.

Join 1,627,652 other subscribers.

Advertisement






netherland biz school Advert

Zenith Advert
ADVERTISEMENT

Our Digital Network

  • PT Hausa
  • Election Centre
  • Human Trafficking Investigation
  • Centre for Investigative Journalism
  • National Conference
  • Press Attack Tracker
  • PT Academy
  • Dubawa
  • LeaksNG
  • Campus Reporter

Resources

  • Oil & Gas Facts
  • List of Universities in Nigeria
  • LIST: Federal Unity Colleges in Nigeria
  • NYSC Orientation Camps in Nigeria
  • Nigeria’s Federal/States’ Budgets since 2005
  • Malabu Scandal Thread
  • World Cup 2018
  • Panama Papers Game
  • Our Digital Network
  • About Us
  • Resources
  • Projects
  • Data & Infographics
  • DONATE

All content is Copyrighted © 2020 The Premium Times, Nigeria

No Result
View All Result
  • Home
  • COVID-19
  • News
    • Headline Stories
    • Top News
    • More News
    • Foreign
  • Investigations
  • Business
    • News Reports
    • Financial Inclusion
    • Analysis and Data
    • Business Specials
    • Opinion
    • Oil/Gas Reports
      • FAAC Reports
      • Revenue
  • Health
    • News Reports
    • Investigations
    • Data and Infographics
    • Health Specials
    • Features
    • Events
    • Primary Health Tracker
  • Agriculture
    • News Report
    • Research & Innovation
    • Data & Infographics
    • Special Reports/Features
    • Investigations
    • Interviews
    • Markets
  • Arts/Life
    • Arts/Books
    • Kannywood
    • Lifestyle
    • Music
    • Nollywood
    • Travel
  • Sports
    • Football
    • More Sports News
    • Sports Features
  • Projects
    • Panama Papers
    • Paradise Papers
    • Parliament Watch
    • AGAHRIN
  • Opinion
  • PT Hausa
  • The Membership Club
  • Dubawa
    • Dubawa NG
  • About Us
  • Advert Rates
  • Careers
  • Contact Us
  • Digital Store
  • DONATE

All content is Copyrighted © 2020 The Premium Times, Nigeria

Our website uses cookies. By continuing to use this website you are giving consent to cookies being used. Visit our Privacy and Cookie Policy.
loading Cancel
Post was not sent - check your email addresses!
Email check failed, please try again
Sorry, your blog cannot share posts by email.